Merck leverages AI and Azure to transform pharmaceutical innovation
Merck, a leader in the pharmaceutical industry, has adopted Microsoft Azure for its AI-driven initiatives tackling drug discovery, clinical trials optimization, manufacturing, and supply chain transformations. Utilizing Azure's cloud infrastructure and data analytics, Merck collaborates closely with AI leaders like Microsoft to identify and optimize drug candidates faster. The partnership fosters the development of tailored treatments and leverages generative AI for compound and target discovery. Additionally, Merck employs AI to monitor vaccine efficacy, optimize manufacturing using real-time data analysis, and engage in precision medicine applications. This approach has significantly reduced R&D costs and time-to-market for new drugs.